Lv42
508 积分 2023-07-01 加入
Design, synthesis, molecular modeling and evaluation of 2,4-diaminopyrimidine analogues as promising colorectal cancer drugs
10小时前
待确认
Design, synthesis and anticancer evaluation of selective 2,4-disubstituted pyrimidine CDK9 inhibitors
7天前
已完结
Development and structure-activity relationship of tacrine derivatives as highly potent CDK2/9 inhibitors for the treatment of cancer
7天前
已完结
Design, synthesis, molecular modeling and evaluation of 2,4-diaminopyrimidine analogues as promising colorectal cancer drugs
7天前
已完结
Design, synthesis, and activity evaluation of selective CDK9 inhibitors containing indazole fragments
7天前
已完结
Recent Discovery and Development of Inhibitors that Target CDK9 and Their Therapeutic Indications
15天前
已完结
Discovery of Orally Bioavailable and Potent CDK9 Inhibitors for Targeting Transcription Regulation in Triple-Negative Breast Cancer
15天前
已完结
Structure-Guided Discovery of Novel N4-(Substituted Thiazol-2-yl)-N2-(4-Substituted phenyl)pyrimidine-2,4-Diamines as Potent CDK2 and CDK9 Dual Inhibitors with High Oral Bioavailability
15天前
已完结
Discovery and Administration Optimization of Novel Selective CDK9 Inhibitor, 1-7a-B1, for Improved Pharmacokinetics and Antitumor Efficacy In Vivo
15天前
已完结
Ribociclib: First Global Approval
29天前
已完结
皖公网安备34019202002308
